1 / 38

Review of Antibiotics Part 1

Penicillin - Spectrum. Lancfield group streptococciAlpha streptococcus, except pneumococcusEnterococcusOral anaerobes - peptostreptococcus, etc.Treponema pallidum and other spirochetesActinomyces. Penicillin - Mechanism of Action. Penicillin is a beta-lactam antibioticBinds to penicillin b

denton
Download Presentation

Review of Antibiotics Part 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    1. Review of Antibiotics Part 1 Gary R. Skankey, MD, FACP, FIDSA University of Nevada School of Medicine

    2. Penicillin - Spectrum Lancfield group streptococci Alpha streptococcus, except pneumococcus Enterococcus Oral anaerobes - peptostreptococcus, etc. Treponema pallidum and other spirochetes Actinomyces

    3. Penicillin - Mechanism of Action Penicillin is a beta-lactam antibiotic Binds to penicillin binding proteins on bacterial cell surface Inhibits cell wall synthesis

    4. Penicillin and Pneumococcus About 30% resistant, 15% intermediately sensitive Altered PBPs makes penicillin and sometimes cephalosporins ineffective Plasmid mediated,possibly transferred from other species Plasmid also caries resistance genes to other antibiotics: macrolides, tetracyclines, sulfa drugs

    5. Penicillin - Neisseria Increasing resistance due to beta-lactamase production in N. gonnorrhea and N. meningitidis Unless organism proven sensitive, do not use penicillin empirically for meningitis or sexually transmitted disease.

    6. Penicillin - Dosing Mild infections - cellulitis, pharyngitis, etc., Penicillin V 500mg PO QID Penicillin G 1 - 2 million units IV Q4hrs Serious infections - meningitis, endocarditis Penicillin G 4 million units IV Q4hrs. Syphillis latent: 2.4 million units benzathine penicillin IM Q week x 3 weeks neurosyphillis: 4 million units IV Q4hrs x 10 days Adjust dose for renal failure

    7. Penicillin - Clinical Uses Syphillis S. pyogenes pharyngitis Actinomyces infections Subacute bacterial endocarditis due to pcn-sensitive alpha-streptococci Pencillin-sensitive pneumococcal and meningococcal meningitis

    8. Ampicillin - Spectrum Same gram positives as penicillin Enteric gram negatives (if sensitive): E. coli Proteus Salmonella Shigella Respiratory tract gram negatives Haemophillus influenzae, Moraxella morganii Pasteurella moltocida Listeria monocytogenes

    9. Ampicillin and Enteroccocus Weak affinity for penicillin-binding proteins …bacterostatic Must add aminoglycoside (gentamicin) to create bacterocidal regimen E. faecalis usually sensitive E. faecium usually resistant

    10. Ampicillin and Haemophillus About 40% of H. influenzae is resistant Produces beta-lactamase Resistance overcome by use of beta-lactamase inhibitor

    11. Ampicillin and Salmonella Increasing resistance in salmonella makes it unreliable against typhoid fever. About 40% resistance

    12. Ampicillin - Dosing Mild infections - cystitis, pharyngitis Amoxacillin 500 mg PO TID Moderate infections - pyelonephritis, cellulitis, osteomyelitis Ampicillin 1 - 2 gm IV Q6hrs Severe infections - meningitis, endocarditis Ampicillin 2 gm IV Q4hrs Adjust dose for renal failure

    13. Ampicillin - Clinical Uses Amoxacillin for ampicillin-sensitive UTIs In combo with gentamicin for enterococcal endocarditis Listeria monocytogenes infections meningitis bacteremia Cat bite cellulitis + clindamycin Penicillin-sensitive alpha-streptococcal SBE

    14. S. aureus - beta lactamase 1st described in 1945 Confers resistance to penicillin and ampicillin Coded for on plasmid Plasmids also carry resistance to other antibiotics Usually inducible

    16. Beta-lactamase-Resistant Penicillins Methicillin high risk of interstitial nephritis, no longer on market Nafcillin Oxacillin Dicloxacillin (PO)

    17. Nafcillin/Oxacillin - Spectrum Oxacillin-sensitive S. aureas Oxacillin-sensitive coagulase negative staph Okay against Lancfield group streptococci and viridans streptococci, but there are better drugs for these No gram negative or anaerobic coverage to speak of

    18. Nafcillin/Oxacillin - Pearls Most potent anti-staph drug made Excellent CNS penetration (staph meningitis) No dose adjustment for renal failure predominantly hepatic excretion Watch out for: leukopenia thrombocytopenia interstitial nephritis

    19. Nafcillin/Oxacillin - Clinical Uses All MSSA infections: Endocarditis Meningitis Osteomyelitis Pneumonia Abscesses Cellulitis

    20. Anti-pseudomonal Penicillins Carbenicillin no longer on the market Ticarcillin only on market as Timentin Piperacillin hard to get as piperacillin alone, usually only available as Zosyn

    21. Piperacillin - Spectrum Pseudomonas Enterobacteriacae group Beta-lactamase negative Moraxella, Neisseria, Haemophillus Same gram positive spectrum as penicillin Same anaerobic spectrum as penicillin

    22. Piperacillin dosing Mild to moderate gram negative (non-pseudomonal) or streptococcal infections 3 gm IV Q6 hrs. Moderate to severe pseudomonal infections 3 gm IV Q4 hrs. Or Piperacillin/tazobactam 3.375 gm IV Q4 hrs

    23. Beta-lactam/Beta-lactamase Inhibitor Combinations Unasyn ampicillin/sulbactam Timentin ticarcillin/clavulenate Zosyn piperacillin/tazobactam

    24. Unasyn - Spectrum Streptococci MSSA All anaerobes Beta-lactamase-producing gram negatives Enterococcus - bacterostatic Penicillin-sensitive pneumococcus

    25. Unasyn - Dosing Mild infections 1.5 gm IV Q6 hrs. Moderate to severe infections 3.0 gm IV Q6 hrs. Adjust dose for renal failure

    26. Unasyn - Clinical Uses Head and neck infections Peritonsilar abscess Sinusitis Mastoiditis Mandibular osteomyelitis Actinomyocosis Infected Bite Wounds Human Dog Cat Diabetic Foot infections, including osteomyelitis Culture negative endocarditis

    27. Zosyn - Spectrum Streptococci MSSA All anaerobes Beta-lactamase-producing gram negatives Enterococcus - bacterostatic Piperacillin-sensitive pseudomonas 18 gm per 24 hrs

    28. Zosyn - Dosing Usual dosing 3.375 gm IV Q6 hrs. Fulminant sepsis 4.5 gm IV Q6 hrs. Pseudomonas sepsis 3.375 gm IV Q4 hrs Adjust dose for renal failure

    29. Zosyn - Clinical Uses Intra-abdominal infections Nosocomial aspiration pneumonia Diabetic foot infections when Pseudomonas might be involved Pulmonary infections in patients with bronchiectasis or cystic fibrosis

    30. Cephalosporins Inhibit cell wall synthesis - peptidoglycan Side effects are mild rash eosinophilia leukopenia leukocytosis biliary sludge (ceftriaxone) thromobocytosis

    31. First Generation Cephalosporins Cefazolin - Ancef IV Cephalothin - Keflin IV Cephalexin - Keflex PO Cephradine - Velosef PO Cefadroxil - Duricef PO

    32. Ancef - Spectrum Staphylococcus Streptococcus E. coli, Proteus, Klebsiella if sensitive

    33. Ancef - Clinical Uses Any MSSA infection Cellulitis (2 gm IV Q8 hrs.) Osteomyelitis Endocarditis Pneumonia Not for meningitis Any Lancfield or viridans group streptococcal infections Endocarditis Cellulitis Sensitive enteric gram negative infections UTI

    34. Second Generation Cephalosporins Cefuroxime IV - Zinacef Cefotetan IV - Cefotan Cefoxitin IV - Mefoxin Cefuroxime axitil PO - Ceftin Cefaclor PO - Ceclor Cefprozil PO - Cefzil

    35. Cefuroxime/Cefotetan - Spectrum H. influenzae Anaerobes Staphylococcus Streptococcus Enterobacteriaceae

    36. 1st vs 2nd Generation 1ST GENERATION H. influenzae - S. aureus ++++ Streptococcus ++++ Moraxella - Gram negatives + Anaerobes - 2ND GENERATION H. influenzae ++++ S. aureus +++ Streptococcus ++++ Moraxella ++++ Gram negatives ++ Anaerobes +++

    37. Cefuroxime - Clinical Uses Upper respiratory tract infections sinusitis peritonsilar abscess otitis media etc., Lower respiratory tract infections pneumonia acute bacterial bronchitis Urinary tract infection

    38. Cefotetan/Cefoxitin - Clinical Uses Intra-abdominal infections diverticulitis intra-abdominal abscess peritonitis cholycystitis etc., Osteomyelitis Diabetic foot infections

    39. Third Generation Cephalosporins Cefotaxime IV - Claforan Ceftriaxone IV - Rocephin Ceftazidime IV - Fortaz Cefixime PO - Suprax Cefpodoxime PO - Vantin

    40. Claforan/Rocephin - Spectrum Streptococci Viridans, Lancfield groups, pneumococcus S. aureus Enteric gram negatives H. influenzae Neisseria meningitidis and gonnorrhea some anaerobes

    41. Fortaz - Spectrum All gram negatives, including Pseudomonas Weak if any gram positive coverage No anaerobic coverage

    42. Claforan/Rocephin - Clinical Uses Meningitis - 2gm Q4 hrs/2gm Q12 hrs Community-acquired pneumonia UTI Upper Respiratory Tract Infections sinusitis peritonsilar abscess Intra-abdominal infections

    43. Fortaz - Clinical Uses Hospital-acquired pneumonia Hospital-acquired UTI Post-op meningitis Intra-abdominal infections Pulmonary infections in patients with cystic fibrosis or bronchiectasis Nail-puncture cellulitis/osteomyelitis

    44. Fourth Generation Cephalosporin Cefepime IV - Maxipime

More Related